Market Alert: Fed Cut Hopes Lift ASX After Rough Week
EPX Limited (ASX: EPX) has secured a significant seven-year contract worth approximately AU$5.3 million with RAFED Healthcare Supplies LLC, a subsidiary of a leading UAE healthcare group. The agreement covers the deployment of EPX’s proprietary EDGE technology across 10 hospitals and clinics in the UAE, aiming to reduce energy costs, cut CO2 emissions, and provide reliable sustainability data. The deal adds a new annual contract value exceeding AU$700,000 and highlights EPX’s successful expansion into the healthcare sector.
The tender process was highly competitive, and EPX’s proven track record, alongside recent accreditations as an ESCO and BEMAS provider in the UAE, strengthened its position. The EDGE platform currently manages over 700 buildings across 25 countries, achieving an average 21% reduction in energy use through advanced data analytics and machine learning. This milestone further solidifies EPX’s growth trajectory in the Middle East sustainability market.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Sep 11, 2025
Sep 11, 2025
Sep 11, 2025
Sep 11, 2025
Sep 11, 2025
Sep 11, 2025
Sep 11, 2025
Sep 11, 2025
Sep 11, 2025
Sep 11, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.